Hematologic complications in patients exposed to poly-ADP ribose polymerase inhibitors
Fields of Study & Subjects
PARP inhibition in cancer therapy
Chronic Lymphocytic Leukemia Research
Blood disorders and treatments
Publication details
- Journal / source
- Haematologica
- Volume
- 111
- Issue
- 7
- Pages
- 2451–2456
- Publication date
- 29 January 2026
- Language
- EN